REPL
NASDAQStockReplimune Group, Inc.
$7.67-0.26 (-3.23%)
52-Week Range
$2.81
$12.63
Key Stats
Market Cap
632.9M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.77
Volume
761.7K
Avg Volume
1.4M
Performance
1M
-2.32%
3M
-23.82%
6M
+33.69%
YTD
-14.83%
1Y
-36.09%
3Y
-61.83%
5Y
-77.73%
Price Chart
ETF Exposure
REPL is held by 63 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| CNCR | Loncar Cancer Immunotherapy ETF | 3.54% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 0.95% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.60% |
| MEDX | Horizon Kinetics Medical ETF | 0.58% |
| NIFE | Direxion Fallen Knives ETF | 0.52% |
| CANC | Tema Oncology ETF | 0.51% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.32% |
| XBI | State Street SPDR S&P Biotech ETF | 0.24% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.23% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.13% |
| IWC | iShares Micro-Cap ETF | 0.12% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.09% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.07% |
| IBB | iShares Biotechnology ETF | 0.05% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.05% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.05% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.04% |
| PWS | Pacer WealthShield ETF | 0.04% |
| IWN | iShares Russell 2000 Value ETF | 0.04% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.03% |
| IWM | iShares Russell 2000 ETF | 0.02% |
| RSSL | Global X - Russell 2000 ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.01% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.00% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
Page 1 of 2Next
About REPL ETF Exposure
Replimune Group, Inc. (REPL) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 632.9M, REPL is a widely held institutional stock. The stock currently trades at $7.67. Investors can gain exposure to REPL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold REPL, sorted by portfolio weight.